Quick Answer
CEMTREX INC reported Research And Development Expense of $2.35 million for the year ending 2025.
- CEMTREX INC showed a decrease of -29.9% in Research And Development Expense from 2024 to 2025.
- This data is from CEMTREX INC's annual report (Form 10-K), filed with the SEC on December 29, 2025.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2011: $0.00 | Q4 2012: $0.00 | Q4 2017: $149.2 thousand | Q1 2018: $57.9 thousand | Q2 2018: $2.25 million | Q4 2018: $379.5 thousand | Q1 2019: $471.6 thousand | Q2 2019: $285.9 thousand | Q4 2019: $376.6 thousand | Q1 2020: $404.9 thousand | Q2 2020: $331.9 thousand | Q4 2020: $634.2 thousand | Q1 2021: $641.5 thousand | Q2 2021: $758.0 thousand | Q4 2021: $1.07 million | Q1 2022: $1.24 million | Q2 2022: $1.19 million | Q4 2022: $1.54 million | Q1 2023: $1.62 million | Q2 2023: $1.05 million | Q4 2023: $848.8 thousand | Q1 2024: $951.4 thousand | Q2 2024: $864.5 thousand | Q4 2024: $890.1 thousand | Q1 2025: $777.9 thousand | Q2 2025: $386.6 thousand | Q4 2025: $501.4 thousand.
- Over the full 8 years of available data (2018 to 2025), CEMTREX INC's Research And Development Expense has declined by 57.7%.
- Historical annual values: Fiscal year 2025: $2.35 million | Fiscal year 2024: $3.36 million | Fiscal year 2023: $3.27 million | Fiscal year 2022: $4.44 million | Fiscal year 2021: $3.17 million | Fiscal year 2020: $1.83 million | Fiscal year 2019: $1.48 million | Fiscal year 2018: $5.56 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: